Recursos

Comparison of covered and uncovered self-expandable stents in the treatment of malignant biliary obstruction.

Related Articles Comparison of covered and uncovered self-expandable stents in the treatment of malignant biliary obstruction. Rev Esp Enferm Dig. 2016 May;108(5):246-9 Authors: Flores Carmona DY, Alonso Lárraga JO, Hernández Guerrero A, Ramírez Solís ME Abstract BACKGROUND AND OBJECTIVE: Drainage with metallic stents is the treatment of choice in malignant obstructive jaundice. Technical and clinical success with metallic stents is obtained in over 90% and 80% of cases, respectively. There are self-expandable metallic stents designed to increase permeability. The aim of this study was to describe the results obtained with totally covered self-expandable and uncovered self-expandable metallic stents in the…
Origen: Comparison of covered and uncovered self-expandable stents in the treatment of malignant biliary obstruction. – PubMed

Leer más Sin comentarios

Recursos

Palliative and end of life care for people living with dementia in care homes: part 1.

Related Articles Palliative and end of life care for people living with dementia in care homes: part 1. Nurs Stand. 2016 Jun 22;30(43):54-63 Authors: Mitchell G, Agnelli J, McGreevy J, Diamond M, Roble H, McShane E, Strain J Abstract The terms palliative and end of life care are often used interchangeably and healthcare practitioners may perceive that palliative care is only appropriate during the terminal stages of an illness. This article, the first of two parts, provides healthcare practitioners with an overview of the concept of palliative care. It explains how this can be differentiated from end of life care…
Origen: Palliative and end of life care for people living with dementia in care homes: part 1. – PubMed

Leer más Sin comentarios

Recursos

Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.

Related Articles Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation. J Appl Clin Med Phys. 2016 Nov 08;17(6):6375 Authors: Salek N, Shamsaei M, Ghannadi Maragheh M, Shirvani Arani S, Bahrami Samani A Abstract Skeletal uptake of radiolabeled-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetramethylene phosphoric acid (e.g., 177Lu-DOTMP) complex, is used for bone pain palliation. The moderate energy of β-emitting 177Lu (T½ = 6.7 d, Eβmax = 497keV) has been considered as a potential radionuclide for development of the bone-seeking radiopharmaceutical. Since the specific activity of the radiolabeled carrier molecules should be high, the “no-carrier-added…
Origen: Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation. – PubMed

Leer más Sin comentarios

Recursos

[Update on epidemiology, pathophysiology, diagnosis and treatment of malignant pleural mesothelioma].

Related Articles [Update on epidemiology, pathophysiology, diagnosis and treatment of malignant pleural mesothelioma]. Rev Med Inst Mex Seguro Soc. 2016 Nov-Dec;54(6):770-776 Authors: Gopar-Nieto R, Cabello-López A, Juárez-Pérez CA, Haro-García LC, Jiménez-Ramírez C, Aguilar-Madrid G Abstract Malignant pleural mesothelioma is an occupational tumor caused by asbestos exposure. In Mexico, as asbestos usage is not prohibited, an increase in the number of cases is expected. Asbestos exposure is ubiquitous due to the great amount of products in which it is present. Its carcinogenicity is caused as the inhaled asbestos fibers cannot be eliminated by macrophages and, thus, they travel to the pleura…
Origen: [Update on epidemiology, pathophysiology, diagnosis and treatment of malignant pleural mesothelioma]. – PubMed

Leer más Sin comentarios

Recursos

Using Length of Stay to Control for Unobserved Heterogeneity When Estimating Treatment Effect on Hospital Costs with Observational Data: Issues of Reliability, Robustness, and Usefulness.

Related Articles Using Length of Stay to Control for Unobserved Heterogeneity When Estimating Treatment Effect on Hospital Costs with Observational Data: Issues of Reliability, Robustness, and Usefulness. Health Serv Res. 2016 Oct;51(5):2020-43 Authors: May P, Garrido MM, Cassel JB, Morrison RS, Normand C Abstract OBJECTIVE: To evaluate the sensitivity of treatment effect estimates when length of stay (LOS) is used to control for unobserved heterogeneity when estimating treatment effect on cost of hospital admission with observational data. DATA SOURCES/STUDY SETTING: We used data from a prospective cohort study on the impact of palliative care consultation teams (PCCTs) on direct cost…
Origen: Using Length of Stay to Control for Unobserved Heterogeneity When Estimating Treatment Effect on Hospital Costs with Observational Data: Issues of Reliability, Robustness, and Usefulness. – PubMed

Leer más Sin comentarios

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies